Anti-smoking drugs can increase heart risk, a study has found. According to a New Zealand doctor, the benefits provided by anti-smoking drugs can overshadow the danger of heart diseases.

Champix, a quit-smoking drug, has been very popular among the younger groups and therefore the drug risks the life of such people with heart attacks or other serious heart problems, according to the study.

Medical Advisor for Quit Group Dr. Peter Martin reported to a news channel that smoking cause greater risks to the health than any other disease.

He said, “The risk of smoking goes on year after year whilst the person smokes, but the risk from a drug like Champix goes on for two or three months while the person takes the drug".

He stated that 21% of the young population smoke and around 7000 people in New Zealand are using the drug. Therefore, Champix is needed to help the people to quit smoking.

One of the smokers using Champix said that as she had been smoking for a long time she is already prone to heart disease risk, so the drug won’t be of much harm.

Sonal Singh of Johns Hopkins University School of Medicine said that people use such drugs to quit smoking and to reduce the risk of cardiovascular disease, but such drugs will anyhow lead to heart problems. So problem remains as it is.